A new weight loss drug could beat Ozempic's side effect problem
The Denmark-based drug maker Zealand Pharma said Tuesday that its experimental weight-loss drug could help patients lose pounds with fewer side effects than current anti-obesity medications on the market.
Novo’s New Obesity Drug Is Targeting the Most Dramatic Weight Loss Yet
The drugmaker hopes to show CagriSema leads to at least 25% weight loss, without increased side effects. Its lead in a red-hot market hinges on it.
Teenagers Are Taking New Weight-Loss Drugs, but the Science Is Far from Settled
Wegovy and similar weight-loss medications are becoming widely prescribed for teenagers with obesity, but little is known about their long-term effects
Map Shows States Where Weight Loss Drugs are Most Popular
Kentucky, Alaska and Alabama are the three states where weight loss drugs are most used, and Hawaii, Arizona and Colorado sit at the other end of the spectrum, a report has revealed. Glucagon-like peptide-1 (GLP-1) receptor analogs are drugs that mimic fullness hormone GLP-1 and have been shown to reduce appetite,
Patients Are Suing Over Alleged Side Effects of Weight-Loss Drugs
These drugs are collectively known as GLP-1 agonists because they mimic the body’s natural hormone GLP-1, which regulates appetite and digestion. The medications control blood sugar and help people eat less,
FDA says this weight loss drug shortage is over, but patients worry about cost and availability
Some patients fear tirzepatide, sold by Eli Lilly under the brand names Zepbound and Mounjaro, will be hard to get and prohibitively expensive once compounding pharmacies are no longer producing it.
Weight loss surgeries decrease as more patients seek out medication: Study
A new study shows that the number of bariatric surgeries are decreasing as more patients treating obesity seek out prescription medication options like Ozempic and Wegovy.
Popular weight loss drugs could help with alcohol, opioid addictions: study
A new study suggests weight loss drugs like Ozempic and Mounjaro could provide a promising new treatment for substance use disorders.
US Medicaid programs say cost a key factor for weight-loss drug coverage, survey finds
Most U.S. states do not currently cover highly sought after weight-loss drugs from Novo Nordisk and Eli Lilly in their Medicaid health programs for low income people, citing cost as a key factor, according to a survey conducted by health research firm KFF.
Medicaid covers GLP-1 weight-loss drugs in just 13 states
Only 13 states currently allow Medicaid to cover treatment of obesity using glucagon-like peptide-1 agonist (GLP-1) medications, researchers said.
Medicaid Covers GLP-1 Meds for Obesity in Just 13 States
Expanding Medicaid coverage of these drugs could increase access for the almost 40% of adults and 26% of children with obesity in Medicaid,” wrote the research team led by se
AOL6d
What are the best prescription weight loss pills?
The Strongest Prescription Weight Loss Pills Antiobesity medications are most effective when combined with healthy lifestyle changes, such as improved diet and exercise routines. Making those ...
Americans hungry for weight-loss drugs grapple with supply and insurance hurdles
Those market dynamics will again be in focus when Novo reports results for its diabetes drug Ozempic and weight-loss medicine Wegovy this Wednesday ... Distributors were still working through ...
Rolling Out4d
7 dangers of buying weight loss drugs online that will make you think twice
Drugs and weight loss often go hand in hand ... When you’re facing four-figure monthly costs for prescribed medications, those “amazing deals” popping up in your Facebook feed start looking ...